Cardiovascular Sciences (CVS)- UoB
@CVS_UoB
Followers
1K
Following
1K
Media
855
Statuses
3K
Cardiovascular Sciences @unibirmingham. We are leaders in cardiovascular research, including atrial fibrillation and heart failure.
Birmingham, England
Joined June 2017
Double congratulations to Dr @richardbuka who has just passed his PhD viva and will start a new job in June as an NIHR Clinical Lecturer with us! @bhamplateletgrp.
0
0
12
At @unibirmingham we thrive on delivering new therapies to treat conditions with a clear unmet need. See ⤵️the great work from the Rainger & @McGettrickLab lab @CVS_UoB on their wonder molecule PEPITEM's potential to treat #psoriasis! @UoBAccelerate #TranslationalResearch
Exciting new research from @unibirmingham has shown that a sequence of just three amino acids from the PEPITEM molecule may reduce the severity of #psoriasis, when applied topically in an emollient cream. @CVS_UoB @BirminghamBRC @unibirm_CMH
https://t.co/kLGtwI6ofE
0
2
3
In this real world study of UK patients with type 2 diabetes, the use of GLP-1 receptor agonists was associated with lower mortality, cardiovascular events & costs than standard therapies of insulin or DPP4s especially those of higher risk https://t.co/6iaNSDHVey
@DrDerekConnolly
link.springer.com
Diabetes Therapy - Clinical trials have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce the risk of major adverse cardiovascular events (MACE) in adults with...
0
0
1
A new @unibirmingham paper from Prof Helen McGettrick and Prof Asif Iqbal could pave the way for new treatments to prevent vascular disease. The study highlights the impact that blood flow patterns have on vascular health. https://t.co/UUUoXEeV92
@CVS_UoB @UoBinfectionsch
0
3
5
Be aggressive with SBP in DM💥 In patients with type 2 diabetes & an🔼risk of CVD, the incidence of major cardiovascular events was lower with intensive treatment targeting a systolic blood pressure of <120 mmHg than with standard treatment of< 140 mmHg https://t.co/uaR6TPvaTh
nejm.org
Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press...
1
3
19
New research will consider how genetic mutations that cause abnormal bleeding appear to protect against deep vein thrombosis (DVT): https://t.co/43jEGyyICm
@neilvmorgan @bhamplateletgrp @bhfprofessional @unibirm_CMH #deepveinthrombosis #Research
birmingham.ac.uk
Professor Neil Morgan has been awarded a research grant to investigate the role of genetic mutations in preventing thrombosis.
1
0
10
🎉 Huge congratulations to @JenefaBegum for presenting an amazing poster at the ECCO25conference ! Well done! 👏 #ProudMoment @unibirm_CMH @CVS_UoB @McGettrickLab
1
3
9
A 240-year-old drug called digoxin could save the @NHS at least £100 million each year when treating older patients with #atrialfibrillation and #HeartFailure: https://t.co/xUCVgKKtC3 Published in @Heart_BMJ
https://t.co/rbMmt1WzBF
@NIHRresearch
heart.bmj.com
Background Atrial fibrillation (AF) is a major and increasing burden on health services. This study aimed to evaluate the cost-effectiveness of digoxin versus beta-blockers for heart rate control in...
1
0
4
Electrical signals from the heart make it beat in a regular and coordinated way. But sometimes, this electrical system can go wrong and lead to major problems for patients: https://t.co/RmiTsWwfK2
@DaRe2ThinkTrial #HEART @unibirm_CMH
birmingham.ac.uk
When the heart skips a beat: research from discovery science through to benefits for patients and the NHS.
1
0
2
Research from our thrombo-inflammation theme found that a 240-year-old drug could save the NHS at least £100M each year when treating older patients with #AtrialFibrillation and heart failure compared with usual treatment ➡️ https://t.co/W7R7EdbO3z Published in @Heart_BMJ
0
1
2
Throughout @unibirmingham's 125 year history, researchers have been leading innovation in heart and circulatory disease. Learn more about this progress and the modern-day research to keep hearts beating steadily. @unibirm_CMH @CVS_UoB #ValentinesDay
https://t.co/PlbHpmYu2u
1
2
3
Today we welcomed visitors from @TheBHF to @unibirmingham. We held a mini-symposium to talk through the new BHF strategy and how we can work together on upcoming opportunities. @unibirm_CMH
0
2
12
Congratulations Dr Dr Ashwin Roy (@ashwinroy90)! Thanks to examiners Professor D Hughes and Dr P Woolfson for giving Ash a good mental workout during the PhD viva, to Prof R Bicknell for chairing and to Prof Rick Steeds for being supervisor for this great project. @CVS_UoB
1
2
10
Congratulations to Dr George Ronson and Dr Juma el-Awaisi who are the recipients of the 2025 Springboard Fellowships! 🎉 @jawaisi @IcgsUob @CVS_UoB
Congratulations to Dr George Ronson and Dr Juma el-Awaisi, who have been announced as this year's recipients of the Springboard Fellowship! The scheme supports early career researchers in developing independent research programmes. @jawaisi @UoBmedicalsci
https://t.co/PyvtAg69aG
0
1
3
Join our SMQB Artists in Residence in an insightful free public webinar to discuss their experiences of collaborating with scientists and the dynamic intersection of art and science. 🎨🧪 More info here: https://t.co/9ypjV8S4dq
#artandscience
#Webinar #Biomedicine #MedTech
0
7
9
The Deadline is Approaching!! Abstract Submission ISHR 2025 Nara, Japan.
0
13
18
✨ Redefining CPVT as a neurocardiac condition ✨ My latest research, now in preprint. You know you’ve been working hard when you produce a 3-author paper with award-winning results 💪 🎉 @amsterdamumc
https://t.co/DSCOZRs31a
biorxiv.org
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome characterised by adrenergic activity-induced sudden cardiac death. It is most often caused by mutati...
0
2
12
@TheBHF CSO Prof Bryan Williams & MO Prof James Leiper presenting new directions and strategies here at @unibirm_CMH @CVS_UoB @unibirmingham
0
1
8
It is actually a postdoc but please DM me if interested (or apply straighaway) 😀 https://t.co/wCiICFegCf
@ISHR_NAS @ISHR_ES @ISHR_LAT @ISHR_ECI @ECI_ISHR @ISHR_AUS @36th_ISHR2021 @AHAScience @escardio
Interested in doing a PhD in cardiovascular research at the University of Birmingham in an excellent team lead by @PavlovicDavor ? See the following link! https://t.co/4XlQvi81QK
0
3
6